Processing .....please wait.. 
The article has been forwarded.... 
British pharma company eyes Indian deals
Friday, 01 October 2004, 19:30 IST
LONDON: Two major Indian companies are close to agreeing to deals with British firm Pharmaceutical Profiles.
The Nottingham-based pharmaceuticals company has been targeting India as a potential growth area for the past two years. Now it expects to enter into deals worth £400,000 over the next six to nine months.
"It's very positive," said business development director Paul Clewlow.
"We have been talking seriously to a couple of companies and have done some quotations for one of them. If we get two projects with them, the value is about £400,000."
"Although a lot of the Indian companies produce copycat drugs, there are some who are looking to develop their own medicines.
"They want to use our new methods to put their potential new medicines through testing more quickly."
Reports say in particular, Indian pharmaceutical companies are keen to utilise the Pharmaceutical Profiles' human drug absorption (HDA), microdosing and gastrointestinal studies.
The HDA technology involves the use of a device called Enterion, known as a miniature cruise missile.
It is a radio-controlled capsule that is swallowed by volunteer patients and allows trial drugs to be released at a precise point in the digestive tract, vital for companies developing drugs.
Source: IANS
Source: IANS